UK-EU SPS negotiations: Your questions answered on precision breeding

What changes will there be to rules governing precision breeding rules in England?

Will the UK lose the ability to research Precision Bred Organisms?

No. The UK will align on EU New Genomic Technology Legislation recently approved by the EU,  enabling NGTs (new genomic techniques) for plants.

Until this legislation is active, the Government has secured a bridging mechanism to allow UK research to continue for PB plant organisms. 

The EU has not made any proposals on NGTs for livestock at this stage.

Defra has retained powers under the English Precision Breeding Act to introduce secondary legislation on PBOs for livestock, providing flexibility as part of the Act.  This means that aligning with EU NGT legislation will mean English research in PBOs for animals cannot commence until this law is changed.

It must be noted this implementation for animals in England has been paused pending further evidence. 

Will the UK need to pause research until the EU legislation is active?

No, the Government has negotiated a bridging mechanism so that PB research and development will continue until the EU legislation is active. At this point, the UK will transition across to the EU legislation. 

Where has the EU got to with its own precision breeding legislation?

On 17 June 2026, the European Parliament approved new legislation enabling NGTs for plants in the EU.

This text was published in the EU Official Journal on 26 June 2026 and will enter into force on 16 July 2028. During this two-year implementation period the European Commission will develop the necessary secondary legislation and implementing acts.

The NFU’s BAB office in Brussels is engaging on the development of this secondary legislation.

Will changes to PB regulations make British plant breeders less competitive?

This will depend on how the EU approval process operates in practice, along with any implementing or delegating acts.

The EU's NGT framework is narrower than the English precision breeding framework, including limitations on the types of genetic changes that can qualify. This could mean some products developed for the English market may require additional approval or may not qualify under the equivalent EU category, potentially reducing access to innovations and increasing compliance costs for businesses operating across both markets.

Conversely, alignment with the EU legislation could provide access to a larger and more consistent market across Great Britain, Northern Ireland and the EU.

Without alignment, some precision-bred organisms authorised in England could face additional regulatory requirements when marketed in Northern Ireland or the EU.

Check out our other FAQ pages

More on the UK-EU SPS negotiations

This page was first published on 20 November 2026.


Ask us a question about this page

Once you have submitted your query someone from NFU CallFirst will contact you. If needed, your query will then be passed to the appropriate NFU policy team.

You have 0 characters remaining.

By completing the form with your details on this page, you are agreeing to have this information sent to the NFU for the purposes of contacting you regarding your enquiry. Please take time to read the NFU’s Privacy Notice if you require further information.

}